0.5% fully diluted post-financing is a conditional yes — if the cash and the paper hold up
Asked (summary)
What is the most likely outcome scenario for Hone given its revenue model — acquisition, IPO, or otherwise?
Asked (follow-up)
“let's assume they give me an offer for first AE of .5% of the company, which is $5m given their new $1bn valuation. Should i take it? Or still not ideal given other AE opportunities at AI companies?”
The evidence behind this answer: 17 founding/first-AE equity and pay benchmarks, 12 current Bay Area AI enterprise-sales listings (Anthropic, Glean, Runway, Greptile, HappyRobot), 401 sources of practical stock-option mechanics, and 8 official Hone and Index Ventures pages, researched 2026-10-20. The $1B valuation and 0.5% offer are user-supplied and not independently verified; everything below treats them as conditional inputs. One caution first: 0.5% × $1B is a preferred-round headline mark, not $5M of realizable value — options are common stock behind preferred liquidation rights, diluted, vested, taxed, and illiquid.
Where 0.5% sits against 17 founding-AE equity benchmarks
Each bar is one source's published equity range for a first sales / founding AE hire, % fully diluted. Orange line: the Hone offer at 0.5%. Hover a bar for terms.
Scenario math: what 0.5% could actually become
Illustrative scenarios, not forecasts. Assumes 25–40% future dilution shrinks 0.5% to roughly 0.30–0.375%; bars show nominal gross common-equity proceeds before strike cost, taxes, and liquidation preferences. Near-last-round exits can pay common far less than shown because preferred is paid first; failure or a license-and-hire pays zero.
Verdict: conditional yes. If the 0.5% is post-financing, fully diluted after any pool increase, board-approved, with a known 409A strike, sufficient guaranteed first-year cash, and a clean commission plan — take it over a later-stage AI AE seat. If the denominator is ambiguous, the grant is discretionary, the exercise window is punitive, or the cash is far below market, the later-stage role wins on risk-adjusted terms.
What the charts cannot say
The grant is inside credible founding-AE bands (0.4–1.0% is the common enterprise range) but unusually generous for an employee-18 stage at a unicorn-level preferred mark — most 0.5%+ grants in the benchmarks attach to seed-stage risk, not a $1B round. scalerr.com
At Seed stage, common-stock 409A fair value typically runs 10–20% of the preferred price, and in exits below 1.5× the last round common holders received 20–40% less than their ownership implied — the $5M headline is not employee value. stealthagents.com
Only about 25% of the grant vests after year one under a standard 4-year/1-year-cliff schedule, and leaving typically gives 90 days to exercise or forfeit — job durability and exercise terms matter as much as the percentage. startupscience.io
Later-stage AI cash is real but bounded: upper advertised cash/OTE in the comparison set runs about $415K–$500K (Glean $375–415K OTE, Anthropic $380–450K base, Greptile $280–450K OTE, Runway $350–425K, HappyRobot $400–500K) — a four-year cash edge likely smaller than a genuine 0.5% grant's upside. revops.cloudtask.com
Hone itself is a $60M Benchmark/Index seed building outcome-owning "Engines"; official pages show named testimonials and deployments across revenue, procurement, risk, product and operations, but publish no revenue or pricing — commercial traction is unverified. indexventures.com
Hone at 0.5% versus a later-stage AI AE seat
Choose Hone when
0.5% is post-financing and fully diluted after any financing-related pool increase
The grant is formally board-approved and the 409A strike price is known
Base cash is sufficient and at least six months of year-one variable is guaranteed or protected
The commission plan does not make you bear implementation or consumption risk outside your control
Favor the later-stage company when
Hone's cash is far below the ~$375–500K upper market cash in the listings set
The 0.5% is quoted pre-financing or on an ambiguous denominator
The grant is discretionary or milestone-only, or the exercise window is punitive
The role could be terminated before the cliff without protection
Never compare offers on percentage alone: compare expected cash over 24 months, ownership after likely dilution, vesting probability, strike cost, tax burden, liquidity horizon, and career value.
Minimum protections to negotiate before saying yes
A suggested ask list, not standard Hone terms.
Competitive early-stage OTE with a 55/45 or 60/40 pay mix while the sales motion is built
Six to twelve months of nonrecoverable ramp guarantee
Commission on a committed annual credit floor at signing, plus expansion and overage
Written credit for founder-sourced accounts; uncapped accelerators; limited clawbacks
Four-year vest with one-year cliff, monthly thereafter; extended post-termination exercise window or early exercise
Double-trigger acceleration; a refresh or milestone grant for building the sales organization
The rows behind the answer
17 founding-AE equity benchmarks and 12 Bay Area AI sales listings. Third-party listings are directional and should be verified.
Set
Role / company
Equity % FD
Cash (USD)
Source
Method: 17 founding/first-AE compensation benchmarks and 12 current Bay Area AI enterprise-sales listings with source URLs, plus 401 stock-option mechanics sources and 8 official Hone/Index pages, researched 2026-10-20. Equity figures are percentage of fully diluted shares as published by each source; cash figures are advertised base or on-target earnings. Scenario bars are illustrative gross proceeds before strike cost, taxes, and liquidation preferences, assuming 25–40% future dilution. Hone's $1B valuation and the 0.5% offer are user-supplied and unverified. The 401 option-mechanics rows are summarized in prose rather than tabled for space.